These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11387502)

  • 1. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system.
    Zhang Y; Pardridge WM
    Stroke; 2001 Jun; 32(6):1378-84. PubMed ID: 11387502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.
    Zhang Y; Pardridge WM
    Brain Res; 2001 Jan; 889(1-2):49-56. PubMed ID: 11166685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins.
    Pardridge WM
    Adv Exp Med Biol; 2002; 513():397-430. PubMed ID: 12575830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection with noninvasive neurotrophin delivery to the brain.
    Wu D; Pardridge WM
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):254-9. PubMed ID: 9874805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.
    Pardridge WM; Wu D; Sakane T
    Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector.
    Song BW; Vinters HV; Wu D; Pardridge WM
    J Pharmacol Exp Ther; 2002 May; 301(2):605-10. PubMed ID: 11961063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
    Pardridge WM; Kang YS; Buciak JL
    Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion.
    Zhang Y; Pardridge WM
    Brain Res; 2006 Sep; 1111(1):227-9. PubMed ID: 16884698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat.
    Ferrer I; Krupinski J; Goutan E; Martí E; Ambrosio S; Arenas E
    Acta Neuropathol; 2001 Mar; 101(3):229-38. PubMed ID: 11307622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
    Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
    Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection in experimental stroke with targeted neurotrophins.
    Wu D
    NeuroRx; 2005 Jan; 2(1):120-8. PubMed ID: 15717063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.
    Schäbitz WR; Hoffmann TT; Heiland S; Kollmar R; Bardutzky J; Sommer C; Schwab S
    Stroke; 2001 May; 32(5):1226-33. PubMed ID: 11340238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.
    Schäbitz WR; Sommer C; Zoder W; Kiessling M; Schwaninger M; Schwab S
    Stroke; 2000 Sep; 31(9):2212-7. PubMed ID: 10978054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
    Wu D; Song BW; Vinters HV; Pardridge WM
    J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of poly(lactic-co-glycolic acid) nanoparticle-bound brain-derived neurotrophic factor in a permanent middle cerebral artery occlusion model of ischemia in rats.
    Kamarudin SN; Iezhitsa I; Tripathy M; Alyautdin R; Ismail NM
    Acta Neurobiol Exp (Wars); 2020; 80(1):1-18. PubMed ID: 32214270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat.
    Reglodi D; Somogyvari-Vigh A; Vigh S; Kozicz T; Arimura A
    Stroke; 2000 Jun; 31(6):1411-7. PubMed ID: 10835464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
    Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
    Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor.
    Yanamoto H; Nagata I; Sakata M; Zhang Z; Tohnai N; Sakai H; Kikuchi H
    Brain Res; 2000 Mar; 859(2):240-8. PubMed ID: 10719070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.